Navigation Links
WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement

SHANGHAI, Jan. 8, 2016 /PRNewswire/ -- WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, today congratulated Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ), a well-established Chinese pharmaceutical company that is a subsidiary of Sino Biopharmaceutical Ltd., and Janssen Pharmaceuticals Inc. (Janssen), a leading global pharmaceutical company, for having reached an exclusive license agreement. Under this agreement, CTTQ grants Janssen rights to develop and commercialize an undisclosed immuno-modulating agent to treat chronic hepatitis B virus (HBV) infection globally outside China. Both CTTQ and Janssen are long-time collaboration partners of WuXi. In 2013, CTTQ signed a contract with WuXi to discover anti-HBV small-molecule drugs. WuXi provided end-to-end integrated research services on the compound that is the subject of this license agreement.

Hepatitis B is a serious and potentially fatal infectious disease afflicting more than 350 million patients worldwide. China has the world's largest hepatitis B patient population. Currently there is no cure for the disease, and effective new drugs are urgently needed.

"We congratulate CTTQ and Janssen on this important agreement," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "WuXi is proud to have played a part in this collaboration to bring an innovative drug candidate closer to hepatitis B patients in China and around the world."

About WuXi AppTec

WuXi AppTec is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States. As a research-driven and customer-focused company, WuXi provides pharmaceutical, biotechnology, and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi is also building a platform to provide clinical diagnostic services directly to physicians and their patients globally. WuXi's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.

For more information, please contact:
Aaron Shi
Director of Corporate Communications
+86-21 5046-4362

Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi AppTec Denies Issuing Press Release Regarding Great Basin Scientific
2. Med Data Quest Tackles Oncology Informatics Challenges with WuXi AppTec
3. Nobel Prize Laureate Professor Barry Sharpless Visits WuXi AppTec Headquarters in Shanghai
4. WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax
5. WuXi AppTec Successfully Completes Its First 2000L Disposable Bioreactor Run Using an NS0 Cell Line, Marking an Industry Milestone
6. National Photonics Initiative Congratulates Industry Partner Hamamatsu on Contributions to Nobel Prize-Winning Research
7. North American Cannabis Holdings Congratulates JV Partner NaturesComfortMeds on Award of Two US Patents
8. OTC Markets Group Congratulates Aethlon Medical on NASDAQ Listing
9. OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing
10. Kids v Cancer Congratulates United Therapeutics on Receiving Priority Review Voucher Through the Creating Hope Act
11. WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA
Post Your Comments:
(Date:9/7/2018)... ... 07, 2018 , ... New York City is currently the epicenter of the ... of claiming the fourth and final jewel in the 2018 grand slam crown – ... Seldom, however, will the players’ footwork be highlighted. , “Today’s tennis isn’t that of ...
(Date:9/1/2018)... ... August 31, 2018 , ... Precision Orthopedics & Sports Medicine ... in Irving and Southlake. Fellowship trained in Spine Surgery, Dr. Gengler will practice ... John Milani, Dr. Jaytinder Sandhu, and Dr. Tariq Hendawi beginning September 4, 2018. ...
(Date:9/1/2018)... (PRWEB) , ... September 01, 2018 , ... ... Inc. ( Shaw ) focuses on the company’s continued efforts to “Create a ... to healthier environments and preservation of natural resources. , “2017 was a ...
Breaking Medicine Technology:
(Date:9/7/2018)... ... 07, 2018 , ... Start your engines and race to the new ... to choose. Pedal power is the name of the game here – whether it’s ... on the miniature Indianapolis Motor Speedway oval. , The timing couldn’t be better with ...
(Date:9/2/2018)... TRUMBULL, Conn. (PRWEB) , ... ... ... Aesthetics & Mammography is proud to add HydraFacial MD® Elite to its ... treatment that uses patented, vortex-suction technology and an infusion of clinically-proven ingredients ...
(Date:9/1/2018)... ... ... Alice Branton shared her personal story on NBC Daytime about how her ... , With all the medical advancements over the last hundred years, vitamin D ... problem worldwide irrespective of age, location, ethnicity, and gender. Even in those residing in ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... neuroimaging capabilities with the addition of an MRI Simulator. In the MRI Simulator, ... including sounds. By engaging in this mock scan experience, research participants become accustomed ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... the impact of a biofield energy treated nutraceutical to improve overall immunity and ... immune function and blood, as well as, inflammation. The following data was reported:, ...
Breaking Medicine News(10 mins):